Clinical TrialsSearch results
Number of results: 372
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Neo-adjuvant therapy with paclitaxel followed by FEC fluoraouracil, epirubicin and cyclophosphamide) for primary breast cancer(KBC-SG0801)
- Primary breast cancer
- Kyushu Breast Cancer Study Group
- 2009-02-27
Recruiting
- Study to Evaluate the Efficacy and Safety of K-808 (pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment
- Primary Biliary Cholangitis
- Tanigawa Ryohei
- 2024-01-18
Not yet recruiting
- A Confirmatory Study (Phase 3) of KC-8025 in Patients with Primary Biliary Cholangitis and Inadequate Response to or Intolerance of Ursodeoxycholic Acid
- Primary Biliary Cholangitis
- Kawabata Hideki
- 2024-11-06
Other
- Study of imatinib monotherapy and combination of imatinib with IFN or cytarabine ocfosfate for chronic-phase CML (JALSG CML202 Study)
- Previously untreated chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2005-09-10
Other
- Phase III Randomized Study of Imatinib therapy in chornic phase chronic myeloid leukemia comparing standard dose-escalation with progressive dose-escalation (JALSG CML207study)
- Previously untreated Chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2007-09-15
Other
- Randomized phase III trial of erlotinib versus docetaxel for patients with previously treated advanced non-small cell lung cancer
- Previously treated non-small cell lung cancer
- National Hospital Organization Headquarters Center for Support and Education of Clinical Research
- 2009-08-11
Other
- Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14)
- previouly untreated advanced stage Hodgkin lymphoma (stage II, III, IVy)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30
Other
- Phase II study of ABV with increased dose of adriamycin (ADM) and deleted DTIC followed by adjuvant involved-field radiotherapy (ABV/IFRT) to residual or initial bulky tumor for the previously untreated patients with advanced Hodgkin's disease (stage IB, IIB, III, IV or bulky). (JCOG9705)
- previouly untreated advanced stage Hodgkin lymphoma (stage IB, IIB, III, IV, or bulky)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-18
Recruiting
- Evaluation of antibody production after vaccination with COVID-19 in volunteer donors
- Prevention of infectious diseases by SARS-CoV-2
- Kawasaki Tatsuhiko
- 2022-03-03
Other
- Preclinical Cushing's syndrome in diabetes mellitus of Japan
- preclinical Cushing's syndrome
- National Hospital Organization, Kyoto Medical Center
- 2006-08-01